Ofev (nintedanib) is a treatment used for patients with idiopathic pulmonary fibrosis (IPF). It is an anti-fibrotic drug that was approved by the FDA in October 2014 to help slow down the progression of the disease. Here are some of the most frequently asked questions about Ofev from the manufacturers, Boehringer Ingelheim.
How will Ofev help me?
In patients with a forced vital capacity (FVC) of 50 percent predicted or higher, it slows down the progression of the disease. The drug also works by reducing acute exacerbations of the disease up to 50 percent.
How do I take Ofev?
Ofev comes in capsule form and one 150mg tablet should be taken twice a day with meals. If you experience any side effects, your doctor may reduce your dose to 100mg twice a day. If side effects persist with the lower dosage your doctor may advise you discontinue the medication.